BioNexus Gene Lab Corp. Increase (Decrease) in Customer Advances
BioNexus Gene Lab Corp. (BGLC) reported Increase (Decrease) in Customer Advances of -$34 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › ASU 2014-09 Transition
us-gaap:IncreaseDecreaseInCustomerAdvances · last filed 2026-08-14
- BioNexus Gene Lab Corp. increase (decrease) in customer advances for the quarter ending 2026-06-30 was -$65.00.
- BioNexus Gene Lab Corp. increase (decrease) in customer advances for the quarter ending 2026-03-31 was $31.00.
- BioNexus Gene Lab Corp. increase (decrease) in customer advances for the quarter ending 2025-12-31 was -$2.88K, a 103.94% decline year-over-year.
- BioNexus Gene Lab Corp. increase (decrease) in customer advances for the quarter ending 2025-09-30 was -$84.00, a 100.50% decline year-over-year.
- BioNexus Gene Lab Corp. increase (decrease) in customer advances for fiscal 2025 was -$87.49K, a 191.25% decline from fiscal 2024.
- BioNexus Gene Lab Corp. increase (decrease) in customer advances for fiscal 2024 was $95.88K.
- BioNexus Gene Lab Corp. increase (decrease) in customer advances for fiscal 2023 was -$23.12K.
- BioNexus Gene Lab Corp. increase (decrease) in customer advances for fiscal 2022 was -$7.18K, a 123.70% decline from fiscal 2021.
| Period end | Increase (Decrease) in Customer Advances 3 month | Increase (Decrease) in Customer Advances 6 month | Increase (Decrease) in Customer Advances 9 month | Increase (Decrease) in Customer Advances 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$65.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$34.00 10-Q · filed 2026-08-14 | -$2.91K derived: sum of 3 quarters · filed 2026-08-14 | -$3.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $31.00 10-Q · filed 2026-05-15 | -$2.85K derived: sum of 2 quarters · filed 2026-05-15 | -$2.93K derived: sum of 3 quarters · filed 2026-05-15 | -$13.55K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$2.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$2.96K derived: sum of 2 quarters · filed 2026-04-14 | -$13.58K derived: sum of 3 quarters · filed 2026-08-14 | -$87.49K 10-K · filed 2026-04-14 |
| 2025-09-30 | -$84.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$10.70K derived: sum of 2 quarters · filed 2026-08-14 | -$84.61K 10-Q · filed 2025-11-14 | -$11.57K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$10.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$84.53K 10-Q · filed 2026-08-14 | -$11.49K derived: sum of 3 quarters · filed 2026-08-14 | $5.41K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$73.92K 10-Q · filed 2026-05-15 | -$870.00 derived: sum of 2 quarters · filed 2026-05-15 | $16.03K derived: sum of 3 quarters · filed 2026-05-15 | $16.39K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $73.05K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $89.94K derived: sum of 2 quarters · filed 2026-04-14 | $90.30K derived: sum of 3 quarters · filed 2026-04-14 | $95.88K 10-K · filed 2026-04-14 |
| 2024-09-30 | $16.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $17.26K derived: sum of 2 quarters · filed 2025-11-14 | $22.83K 10-Q · filed 2025-11-14 | $14.62K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $359.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $5.94K 10-Q · filed 2025-08-18 | -$2.28K derived: sum of 3 quarters · filed 2025-08-18 | -$1.16K derived: sum of 4 quarters · filed 2025-08-18 |
| 2024-03-31 | $5.58K 10-Q · filed 2025-05-15 | -$2.64K derived: sum of 2 quarters · filed 2025-05-15 | -$1.52K derived: sum of 3 quarters · filed 2025-05-15 | -$9.74K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$8.22K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$7.09K derived: sum of 2 quarters · filed 2025-04-15 | -$15.32K derived: sum of 3 quarters · filed 2025-04-15 | -$23.12K 10-K · filed 2025-04-15 |
| 2023-09-30 | $1.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | -$7.10K derived: sum of 2 quarters · filed 2024-11-15 | -$14.90K 10-Q · filed 2024-11-15 | -$279.00 derived: sum of 4 quarters · filed 2024-11-15 |
| 2023-06-30 | -$8.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$16.03K 10-Q · filed 2024-08-14 | -$1.40K derived: sum of 3 quarters · filed 2024-08-14 | $7.09K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$7.80K 10-Q · filed 2024-05-15 | $6.83K derived: sum of 2 quarters · filed 2024-05-15 | $15.32K derived: sum of 3 quarters · filed 2024-05-15 | $15.21K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $14.63K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $23.12K derived: sum of 2 quarters · filed 2024-04-16 | $23.02K derived: sum of 3 quarters · filed 2024-04-16 | -$7.18K 10-K · filed 2024-04-16 |
| 2022-09-30 | $8.50K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | $8.39K derived: sum of 2 quarters · filed 2024-03-26 | -$21.81K 10-Q/A · filed 2024-03-26 | $8.50K derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-06-30 | -$107.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$30.31K 10-Q · filed 2023-08-16 | $0.00 derived: sum of 3 quarters · filed 2023-08-16 | $0.00 derived: sum of 4 quarters · filed 2023-08-16 |
| 2022-03-31 | -$30.20K 10-Q · filed 2023-05-09 | $107.00 derived: sum of 2 quarters · filed 2023-05-09 | $107.00 derived: sum of 3 quarters · filed 2023-05-09 | $107.00 derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $30.31K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $30.31K derived: sum of 2 quarters · filed 2023-03-31 | $30.31K derived: sum of 3 quarters · filed 2023-03-31 | $30.31K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |